Ladja, Ridzsal B.
HRN: 21-83-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/22/2023
02/28/2023
IVTT
550MG
Q8
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes